These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 12445189

  • 21. Histamine H1 and H2 receptor antagonists accelerate skin barrier repair and prevent epidermal hyperplasia induced by barrier disruption in a dry environment.
    Ashida Y, Denda M, Hirao T.
    J Invest Dermatol; 2001 Feb; 116(2):261-5. PubMed ID: 11180002
    [Abstract] [Full Text] [Related]

  • 22. Topical application of neuronal nitric oxide synthase inhibitor accelerates cutaneous barrier recovery and prevents epidermal hyperplasia induced by barrier disruption.
    Ikeyama K, Fuziwara S, Denda M.
    J Invest Dermatol; 2007 Jul; 127(7):1713-9. PubMed ID: 17363920
    [Abstract] [Full Text] [Related]

  • 23. Topical application of TRPM8 agonists accelerates skin permeability barrier recovery and reduces epidermal proliferation induced by barrier insult: role of cold-sensitive TRP receptors in epidermal permeability barrier homoeostasis.
    Denda M, Tsutsumi M, Denda S.
    Exp Dermatol; 2010 Sep; 19(9):791-5. PubMed ID: 20636355
    [Abstract] [Full Text] [Related]

  • 24. Modulation of extracellular GABA levels in the retina by activation of glial P2X-purinoceptors.
    Neal MJ, Cunningham JR, Dent Z.
    Br J Pharmacol; 1998 May; 124(2):317-22. PubMed ID: 9641548
    [Abstract] [Full Text] [Related]

  • 25. Pharmacological and molecular characterization of P2X receptors in rat pelvic ganglion neurons.
    Zhong Y, Dunn PM, Xiang Z, Bo X, Burnstock G.
    Br J Pharmacol; 1998 Oct; 125(4):771-81. PubMed ID: 9831914
    [Abstract] [Full Text] [Related]

  • 26. ATPgammaS enhances the production of inflammatory mediators by a human dermal endothelial cell line via purinergic receptor signaling.
    Seiffert K, Ding W, Wagner JA, Granstein RD.
    J Invest Dermatol; 2006 May; 126(5):1017-27. PubMed ID: 16410784
    [Abstract] [Full Text] [Related]

  • 27. P2X purinergic receptor knockout mice reveal endogenous ATP modulation of both vasopressin and oxytocin release from the intact neurohypophysis.
    Custer EE, Knott TK, Cuadra AE, Ortiz-Miranda S, Lemos JR.
    J Neuroendocrinol; 2012 Apr; 24(4):674-80. PubMed ID: 22340257
    [Abstract] [Full Text] [Related]

  • 28. P2X3 receptor mediates heat hyperalgesia in a rat model of trigeminal neuropathic pain.
    Shinoda M, Kawashima K, Ozaki N, Asai H, Nagamine K, Sugiura Y.
    J Pain; 2007 Jul; 8(7):588-97. PubMed ID: 17481957
    [Abstract] [Full Text] [Related]

  • 29. P2X antagonists inhibit styryl dye entry into hair cells.
    Crumling MA, Tong M, Aschenbach KL, Liu LQ, Pipitone CM, Duncan RK.
    Neuroscience; 2009 Jul 21; 161(4):1144-53. PubMed ID: 19272432
    [Abstract] [Full Text] [Related]

  • 30. Smooth muscle and purinergic contraction of the human, rabbit, rat, and mouse testicular capsule.
    Banks FC, Knight GE, Calvert RC, Turmaine M, Thompson CS, Mikhailidis DP, Morgan RJ, Burnstock G.
    Biol Reprod; 2006 Mar 21; 74(3):473-80. PubMed ID: 16280417
    [Abstract] [Full Text] [Related]

  • 31. TNP-ATP-resistant P2X ionic current on the central terminals and somata of rat primary sensory neurons.
    Tsuzuki K, Ase A, Séguéla P, Nakatsuka T, Wang CY, She JX, Gu JG.
    J Neurophysiol; 2003 Jun 21; 89(6):3235-42. PubMed ID: 12783957
    [Abstract] [Full Text] [Related]

  • 32. P2X3 knock-out mice reveal a major sensory role for urothelially released ATP.
    Vlaskovska M, Kasakov L, Rong W, Bodin P, Bardini M, Cockayne DA, Ford AP, Burnstock G.
    J Neurosci; 2001 Aug 01; 21(15):5670-7. PubMed ID: 11466438
    [Abstract] [Full Text] [Related]

  • 33. Involvement of P2X receptors in the regulation of insulin secretion, proliferation and survival in mouse pancreatic β-cells.
    Ohtani M, Ohura K, Oka T.
    Cell Physiol Biochem; 2011 Aug 01; 28(2):355-66. PubMed ID: 21865744
    [Abstract] [Full Text] [Related]

  • 34. Regulation of the development of allodynia by intrathecally administered P2 purinoceptor agonists and antagonists in mice.
    Fukuhara N, Imai Y, Sakakibara A, Morita K, Kitayama S, Tanne K, Dohi T.
    Neurosci Lett; 2000 Sep 29; 292(1):25-8. PubMed ID: 10996441
    [Abstract] [Full Text] [Related]

  • 35. ATP released from astrocytes during swelling activates chloride channels.
    Darby M, Kuzmiski JB, Panenka W, Feighan D, MacVicar BA.
    J Neurophysiol; 2003 Apr 29; 89(4):1870-7. PubMed ID: 12686569
    [Abstract] [Full Text] [Related]

  • 36. Evidence for the involvement of endogenous ATP and P2X receptors in TMJ pain.
    Oliveira MC, Parada CA, Veiga MC, Rodrigues LR, Barros SP, Tambeli CH.
    Eur J Pain; 2005 Feb 29; 9(1):87-93. PubMed ID: 15629879
    [Abstract] [Full Text] [Related]

  • 37. Allosteric modulation and accelerated resensitization of human P2X(3) receptors by cibacron blue.
    Alexander K, Niforatos W, Bianchi B, Burgard EC, Lynch KJ, Kowaluk EA, Jarvis MF, van Biesen T.
    J Pharmacol Exp Ther; 1999 Dec 29; 291(3):1135-42. PubMed ID: 10565834
    [Abstract] [Full Text] [Related]

  • 38. Characterization of multiple P2X receptors in cultured normal human epidermal keratinocytes.
    Inoue K, Denda M, Tozaki H, Fujishita K, Koizumi S, Inoue K.
    J Invest Dermatol; 2005 Apr 29; 124(4):756-63. PubMed ID: 15816834
    [Abstract] [Full Text] [Related]

  • 39. Comparison of the actions of ATP and UTP and P(2X1) receptors in smooth muscle of the rat tail artery.
    McLaren GJ, Sneddon P, Kennedy C.
    Eur J Pharmacol; 1998 Jun 12; 351(1):139-44. PubMed ID: 9698215
    [Abstract] [Full Text] [Related]

  • 40. Extracellular ATP signaling in equine digital blood vessels.
    Zerpa H, Crawford C, Knight GE, Fordham AF, Janska SE, Peppiatt-Wildman CM, Elliott J, Burnstock G, Wildman SS.
    Eur J Pharmacol; 2013 Feb 28; 702(1-3):242-9. PubMed ID: 23370179
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.